Cobalamin (Vitamin B12) in Canine and Feline Oncology Support

cobalamin (vitamin B12) is covered as nutrient replacement for documented or strongly suspected deficiency; not a universal cancer supplement, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Nutrient replacement for documented or strongly suspected deficiency; not a universal cancer supplement. Cyanocobalamin or another veterinary-selected cobalamin form.

Cyanocobalamin or another veterinary-selected cobalamin form.

Cobalamin is required for normal cellular metabolism, haematopoiesis and neurologic function. Replacement corrects deficiency; it has no established direct antitumour action.

Gastrointestinal lymphoma, chronic enteropathy, pancreatic disease, poor intake or prior surgery may coexist with deficiency. Testing and the underlying diagnosis determine whether replacement belongs in the plan.

Gastrointestinal lymphoma, chronic enteropathy, pancreatic disease, poor intake or prior surgery may coexist with deficiency. Testing and the underlying diagnosis determine whether replacement belongs in the plan.

Oral or parenteral replacement selected from diagnosis, severity and follow-up testing

Studies in hypocobalaminaemic cats with gastrointestinal disease found biochemical and clinical improvement after replacement. A randomized canine trial found oral and parenteral replacement could both restore concentrations in chronic enteropathy. Neither study supports routine supplementation of every oncology patient.

Cobalamin is generally well tolerated, but product quality, route and the reason for deficiency matter. A normal serum value does not always settle functional status, and supplementation can change later test interpretation.

The main risk is diagnostic substitution: giving a vitamin should not replace investigation of malabsorption, pancreatic disease, tumour progression or inadequate nutrition.

This ingredient exists as food supplements and medicines with different quality and claims. The Directory does not classify all B12 products as approved veterinary drugs.

Multi-region availability; product category and authorised claims vary.

Document baseline nutritional assessment, relevant gastrointestinal signs and cobalamin testing, with methylmalonic acid or other markers when the veterinarian considers them useful. Recheck response and investigate persistent weight loss, diarrhoea or anaemia rather than escalating blindly.